Bagsværd, 6 November 2024 - Financial report for the period 1 January 2024 to 30 September 2024 Operating profit increased by ...

In related news, the American Diabetes Association released new consensus considerations and good-practice points for use of ...

Semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee ...

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

Fewer patients experienced a first hospital admission for any indication and for serious adverse events while on semaglutide.

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

SAN ANTONIO — Treatment with once-weekly semaglutide 2.4 mg (Wegovy) significantly reduced hospital admissions for all causes — not just cardiac — and overall hospitalization time in people with ...

Dr. Whit Roberts of Health Utah says he is concerned about the financial costs and health risks potentially posed by popular ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

In a groundbreaking new study, the active ingredient in Ozempic was found to be so effective at treating arthritis that ...